NCT00203112View on ClinicalTrials.gov

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

July 31, 2006

Conditions
Relapse Remitting Multiple Sclerosis
Interventions
DRUG

glatiramer acetate with minocycline

Subcutaneous injection glatiramer acetate 20mg, with oral minocycline 100mg

DRUG

Glatiramer acetate with placebo

Subcutaneous injection glatiramer acetate 20mg, with oral placebo

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT00203112 - Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline | Biotech Hunter | Biotech Hunter